Kadar C-Reactive Protein (CRP) Pasien COVID-19 Gejala Sedang dan Berat di RSU UKI Periode Juni-September 2021

Suryana, Adelia Winanda (2022) Kadar C-Reactive Protein (CRP) Pasien COVID-19 Gejala Sedang dan Berat di RSU UKI Periode Juni-September 2021. S1 thesis, Universitas Kristen Indonesia.

	Text (Hal_Judul_Daftar_Isi_Daftar_Tabel_Daftar_Gambar_Daftar_Singkatan_Daftar_Lampiran_Abstrak) HalJudulDaftarIsiDaftarTabelDaftarGambarDaftarSingkatanDaftarLampiranAbstrak.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (928kB)
	Text (BAB_I) BABI.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (267kB)
	Text (BAB_II) BABII.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (1MB)
	Text (BAB_III) BABIII.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (841kB)
	Text (BAB_IV) BABIV.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (447kB)
	Text (BAB_V) BABV.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (248kB)
	Text (Daftar_Pustaka) DaftarPustaka.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (442kB)
	Text (Lampiran) Lampiran.pdf Restricted to Repository staff only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (686kB)

Abstract

Coronavirus Disease 2019 (COVID-19) adalah penyakit yang disebabkan oleh SARS-CoV-2 dan menyebabkan terjadinya pandemi di dunia. Penderita COVID-19 dapat mengalami gejala terutama seperti demam, batuk kering, sakit kepala, dan sesak napas hingga bisa menjadi pneumonia. Peradangan yang berlebihan dianggap sebagai penyebab utama penyakit kritis dan kematian pada pasien COVID-19. C-Reactive Protein merupakan indikator yang sensitif sebagai penanda awal terjadinya infeksi dan inflamasi. Penelitian ini menyajikan gambaran perbedaan rerata kadar CRP antara pasien terkonfirmasi positif COVID-19 gejala sedang dan berat di RSU UKI periode Juni-September 2021. Desain penelitian adalah potong lintang dengan penyajian data secara deskriptif dan analitik yang diperoleh dari dokumen rekam medik RSU UKI. Rata-rata kadar CRP pasien COVID-19 gejala sedang sebesar 63,705 mg/L dengan jumlah pasien 139 orang. Rata-rata kadar CRP pasien COVID-19 gejala berat sebesar 132,050 mg/L dengan jumlah pasien 57 orang. Hasil yang diperoleh dari uji Mann-Whitney antara kelompok pasien COVID-19 gejala sedang dan berat menunjukkan adanya perbedaan rerata yang bermakna antara kadar CRP gejala sedang dan berat dengan p <0,05./ Coronavirus Disease 2019 (COVID-19) is a disease caused by SARS-CoV-2 and has caused a global pandemic. Patients with COVID-19 can experience symptoms, especially fever, dry cough, headache, and shortness of breath which can lead to pneumonia. Excessive inflammation is considered a leading cause of critical illness and death in COVID-19 patients. C-Reactive Protein is a sensitive indicator as an early marker of infection and inflammation. This study presents an overview of the difference in the mean CRP levels between patients with moderate and severe confirmed positive symptoms of COVID-19 at UKI Hospital for the period June-September 2021. The study design was cross-sectional with descriptive and analytical data presentation obtained from medical record documents at UKI Hospital. The average CRP level of COVID-19 patients with moderate symptoms is 63,705 mg/l with a total of 139 patients. The average CRP level of COVID-19 patients with severe symptoms is 132,050 mg/l with 57 patients. The results obtained from the Mann-Whitney test between groups of patients with moderate and severe symptoms of COVID-19 showed a significant difference in the mean CRP levels between moderate and severe symptoms with p <0.05.

Actions (login required)

View Item